175 related articles for article (PubMed ID: 34607185)
21. Rapid eye movement sleep duration during the multiple sleep latency test to diagnose hypocretin-deficient narcolepsy.
Lopez R; Barateau L; Laura Rassu A; Evangelista E; Chenini S; Scholz S; Jaussent I; Dauvilliers Y
Sleep; 2023 Jan; 46(1):. PubMed ID: 36222741
[TBL] [Abstract][Full Text] [Related]
22. The Sublaterodorsal Tegmental Nucleus Functions to Couple Brain State and Motor Activity during REM Sleep and Wakefulness.
Torontali ZA; Fraigne JJ; Sanghera P; Horner R; Peever J
Curr Biol; 2019 Nov; 29(22):3803-3813.e5. PubMed ID: 31679942
[TBL] [Abstract][Full Text] [Related]
23. Electroencephalogram paroxysmal θ characterizes cataplexy in mice and children.
Vassalli A; Dellepiane JM; Emmenegger Y; Jimenez S; Vandi S; Plazzi G; Franken P; Tafti M
Brain; 2013 May; 136(Pt 5):1592-608. PubMed ID: 23616586
[TBL] [Abstract][Full Text] [Related]
24. Dual orexin and MCH neuron-ablated mice display severe sleep attacks and cataplexy.
Hung CJ; Ono D; Kilduff TS; Yamanaka A
Elife; 2020 Apr; 9():. PubMed ID: 32314734
[TBL] [Abstract][Full Text] [Related]
25. Hypothalamic MCH Neuron Activity Dynamics during Cataplexy of Narcolepsy.
Sun Y; Liu M
eNeuro; 2020; 7(2):. PubMed ID: 32303567
[TBL] [Abstract][Full Text] [Related]
26. Narcolepsies, update in 2023.
Barateau L; Pizza F; Chenini S; Peter-Derex L; Dauvilliers Y
Rev Neurol (Paris); 2023 Oct; 179(7):727-740. PubMed ID: 37634997
[TBL] [Abstract][Full Text] [Related]
27. The effect of intranasal orexin-A (hypocretin-1) on sleep, wakefulness and attention in narcolepsy with cataplexy.
Weinhold SL; Seeck-Hirschner M; Nowak A; Hallschmid M; Göder R; Baier PC
Behav Brain Res; 2014 Apr; 262():8-13. PubMed ID: 24406723
[TBL] [Abstract][Full Text] [Related]
28. REM sleep enhancement and behavioral cataplexy following orexin (hypocretin)-II receptor antisense perfusion in the pontine reticular formation.
Thakkar MM; Ramesh V; Cape EG; Winston S; Strecker RE; McCarley RW
Sleep Res Online; 1999; 2(4):112-20. PubMed ID: 11382892
[TBL] [Abstract][Full Text] [Related]
29. The inappropriate occurrence of rapid eye movement sleep in narcolepsy is not due to a defect in homeostatic regulation of rapid eye movement sleep.
Roman A; Meftah S; Arthaud S; Luppi PH; Peyron C
Sleep; 2018 Jun; 41(6):. PubMed ID: 29522212
[TBL] [Abstract][Full Text] [Related]
30. Transgenic Archaerhodopsin-3 Expression in Hypocretin/Orexin Neurons Engenders Cellular Dysfunction and Features of Type 2 Narcolepsy.
Williams RH; Tsunematsu T; Thomas AM; Bogyo K; Yamanaka A; Kilduff TS
J Neurosci; 2019 Nov; 39(47):9435-9452. PubMed ID: 31628177
[TBL] [Abstract][Full Text] [Related]
31. The development of sleep/wake disruption and cataplexy as hypocretin/orexin neurons degenerate in male vs. female Orexin/tTA; TetO-DTA Mice.
Sun Y; Tisdale R; Park S; Ma SC; Heu J; Haire M; Allocca G; Yamanaka A; Morairty SR; Kilduff TS
Sleep; 2022 Dec; 45(12):. PubMed ID: 35182424
[TBL] [Abstract][Full Text] [Related]
32. Control of motoneuron function and muscle tone during REM sleep, REM sleep behavior disorder and cataplexy/narcolepsy.
Peever J
Arch Ital Biol; 2011 Dec; 149(4):454-66. PubMed ID: 22205591
[TBL] [Abstract][Full Text] [Related]
33. Expression of a poly-glutamine-ataxin-3 transgene in orexin neurons induces narcolepsy-cataplexy in the rat.
Beuckmann CT; Sinton CM; Williams SC; Richardson JA; Hammer RE; Sakurai T; Yanagisawa M
J Neurosci; 2004 May; 24(18):4469-77. PubMed ID: 15128861
[TBL] [Abstract][Full Text] [Related]
34. Prepro-hypocretin (prepro-orexin) expression is unaffected by short-term sleep deprivation in rats and mice.
Terao A; Peyron C; Ding J; Wurts SW; Edgar DM; Heller HC; Kilduff TS
Sleep; 2000 Nov; 23(7):867-74. PubMed ID: 11083595
[TBL] [Abstract][Full Text] [Related]
35. Activity of dorsal raphe cells across the sleep-waking cycle and during cataplexy in narcoleptic dogs.
Wu MF; John J; Boehmer LN; Yau D; Nguyen GB; Siegel JM
J Physiol; 2004 Jan; 554(Pt 1):202-15. PubMed ID: 14678502
[TBL] [Abstract][Full Text] [Related]
36. Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy.
Baumann CR; Khatami R; Werth E; Bassetti CL
J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):402-4. PubMed ID: 16484654
[TBL] [Abstract][Full Text] [Related]
37. Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy.
Andlauer O; Moore H; Hong SC; Dauvilliers Y; Kanbayashi T; Nishino S; Han F; Silber MH; Rico T; Einen M; Kornum BR; Jennum P; Knudsen S; Nevsimalova S; Poli F; Plazzi G; Mignot E
Sleep; 2012 Sep; 35(9):1247-55F. PubMed ID: 22942503
[TBL] [Abstract][Full Text] [Related]
38. Validation of the ICSD-2 criteria for CSF hypocretin-1 measurements in the diagnosis of narcolepsy in the Danish population.
Knudsen S; Jennum PJ; Alving J; Sheikh SP; Gammeltoft S
Sleep; 2010 Feb; 33(2):169-76. PubMed ID: 20175400
[TBL] [Abstract][Full Text] [Related]
39. Clinical features of childhood narcolepsy. Can cataplexy be foretold?
Nevsimalova S; Jara C; Prihodova I; Kemlink D; Sonka K; Skibova J
Eur J Paediatr Neurol; 2011 Jul; 15(4):320-5. PubMed ID: 21345702
[TBL] [Abstract][Full Text] [Related]
40. Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons.
Bourgin P; Huitrón-Résendiz S; Spier AD; Fabre V; Morte B; Criado JR; Sutcliffe JG; Henriksen SJ; de Lecea L
J Neurosci; 2000 Oct; 20(20):7760-5. PubMed ID: 11027239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
